Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Transforming the lives of patients with life-limiting diseases of the nervous system.
Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our innovative, precision-targeted therapeutics.
Legal Name
:
Engrail Therapeutics, Inc.
Headquarters
:
San Diego, California, United States of America
Business Model
:
Founding Date
:
2019
No. of Employees
:
21 to 40
Core Team
:
1.
Vikram Sudarsan
President and CEO
2.
Stephen Cunningham
Co-Founder and Chief Development Officer
Total Funding
$221.0M
Investors
:
1.
Nan Fung Life Sciences
2.
Forbion Capital Partners
3.
F-Prime Capital
4.
Norwest Venture Partners
See More
Frequently Asked Questions
